Hyperphosphatemia in CKD - Part VI This article by Wajeh Y. Qunibi, MD, FACP of the University of Texas Health Sciences Center at San Antonio is the final in a series on managing hyperphosphatemia in CKD patients.

Hyperphosphatemia in CKD - Part V
This article by Neenoo Khosla, MD, and Stuart M. Sprague, DO, of the Northwestern University Feinberg School of Medicine in Chicago, is the fifth in a series on managing hyperphosphatemia in CKD patients.

Hyperphosphatemia in CKD - Part IV
This article by Michal L. Melamed, MD, MHS, of the Albert Einstein College of Medicine of Yeshiva University in Bronx, N.Y., is the fourth is a series on managing hyperphosphatemia in CKD patients.

Hyperphosphatemia in CKD - Part III
This article is the third in a series on hyperphosphatemia management in CKD patients. It is written by Kamyar Kalantar-Zadeh, MD, PhD, MPH, associate professor of medicine, pediatrics, and epidemiology at the David Geffen School of Medicine at the University of California-Los Angeles (UCLA) and director of Dialysis Expansion & Epidemiology in the Harbor-UCLA Division of Nephrology & Hypertension. He also is the Renal & Urology News medical director for nephrology.

Hyperphosphatemia in CKD - Part II
This article is the second in a series on hyperphosphatemia management in CKD patients. It is written by Joseph A. Coladonato, MD, MHS, medical director of South Greensboro Kidney Center, Carolina Kidney Associates, in Greensboro, N.C.

Hyperphosphatemia in CKD - Part I
Click here for the first article, which is by series editor Csaba P. Kovesdy, MD, chief of nephrology at the Salem VA Medical Center in Salem, Va. Dr. Kovesdy discusses whether the scientific evidence justifies the use of phosphate-lowering treatment.